Bernstein SocGen Reiterates Market Perform Rating on Jazz Pharmaceuticals (JAZZ)
June 9, 2026 9:27 AM
Bernstein SocGen Group analyst Jeffrey Walch reiterated a Market Perform rating and $229.00 price target on Jazz Pharmaceuticals (NASDAQ: JAZZ).The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
